Program overview
Fellowship-Programm für Gynäkologische Onkologie is listed as four-year clinical and translational research fellowship leading toward the german gynecologic oncology schwerpunkt offered by Universitätsklinikum Heidelberg – Universitäts-Frauenklinik in Heidelberg, Germany. It is listed under Gynecologic Oncology, with an original program classification of Gynäkologische Onkologie.
Application information
- Deadline / application cycle
- Annual application round opens in January and closes 31 March
- International applicants
- Conditional. The programme is for OB-GYN specialists; physicians trained abroad must obtain recognition of qualifications and German Approbation or Berufserlaubnis before clinical work, then meet the hospital's selection criteria.
- Visa support
- EU/EFTA citizens do not need a work visa; other nationals need an appropriate German residence permit. Employer sponsorship is not published.
- Funding
- Employment and salary terms are not published on the fellowship page; confirm with Universitätsklinikum Heidelberg
- State / region
- Baden-Württemberg
- Language
- German for clinical work; B2 general German and usually a C1 medical-language examination are required for German medical licensure
- Tuition / programme fee
- No programme tuition is published
- Verified as of
- 2026-10-11
Classification
- Directory pathway
- Gynecologic Oncology
- Original classification
- Gynäkologische Onkologie
- Program format
- Four-year clinical and translational research fellowship leading toward the German gynecologic oncology Schwerpunkt
- Accreditation / registry ID
- Not published; confirm with program
- Accreditation status
- Institution-defined fellowship; the programme states that the Landesärztekammer gynecologic oncology designation is an intended outcome
Verify before applying
Program availability, deadlines, eligibility, accreditation, funding, licensing, and immigration requirements can change. Confirm every requirement directly with the institution before making an application or travel decision.